Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |